-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster II Clinically Relevant Abstract

Symposia: Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Letícia Queiroz da Silva1*, Stephany Cares Huber, PhD1*, Beatriz Martinelli, BSc1*, Camilla Maria de Alencar Saraiva, MD2*, Silmara Aparecida De Lima Montalvão, PhD1*, Fernando Ferreira Costa, MD, PhD1,2 and Erich Vinicius De Paula, MD, PhD1,2

1Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
2School of Medical Sciences, University of Campinas, Campinas, Brazil

Jan Astermark1, Shashikant Apte2, Chuhl Joo Lyu3*, Amalie Rhode Høgh Nielsen4*, Sonata Saulyte Trakymiene5*, Jay Jay Thaung Zaw4*, Huyen Tran, Master Clin Epi FRACP FRCPA6, Jerzy Windyga7* and Hermann Eichler, MD8*

1Department of Translational Medicine, Lund University, Lund, Sweden
2Sahyadri Specialty Hospital, Pune, India
3Department of Paediatrics, Yonsei University Severance Hospital, Seoul, Korea, Republic of (South)
4Novo Nordisk, Søborg, Denmark
5Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnus, Lithuania
6Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC, Australia
7Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
8Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and University Hospital, Homburg/Saar, Germany

Grace Tang1*, Rosane Nisenbaum, PhD2*, Rachel Martin, MD3*, Pauline Manuel, BSc4*, Rebecca Sampat, BSc5*, Jerome M. Teitel, MD6, Paula James, MD, FRCPC7 and Michelle Sholzberg, MDCM, MSc8

1Hematology-Oncology Clinical Research Group, Division of Hematology-Oncology, St. Michael's Hospital, Toronto, Canada, Toronto, ON, Canada
2Li Ka Shing Knowledge Institute, Applied Health Research Centre, Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada
3Department of Anesthesia, St. Joseph's Health Centre, Toronto, Canada
4Division of Hematology/Oncology, Department of Medicine, St. Michael's Hospital, Toronto, ON, CAN
5Division of Hematology/Oncology, Department of Medicine, St. Michael's Hospital, Toronto, Canada
6St. Michael's Hospital, Toronto, ON, CAN
7Division of Hematology, Department of Medicine, Queen's University, Kingston, ON, Canada
8Division of Hematology-Oncology, St. Michael's Hospital, Toronto, ON, Canada

Amelia K Haj, MD, PhD1,2,3, Sean J. Jurgens, MD MSc2,4,5*, Xin Wang, MBBS2,3*, Justine Ryu, MD2,6, Seung Hoan Choi, PhD7*, Simone Sanna-Cherchi, MD8*, Patrick Ellinor, MD, PhD2,3,4* and Pavan K Bendapudi, MD2,3,9,10

1Department of Pathology, Massachusetts General Hospital, Cambridge, MA
2The Broad Institute of MIT and Harvard, Cambridge, MA
3Harvard Medical School, Boston, MA
4Massachusetts General Hospital, Boston, MA
5Department of Experimental Cardiology, University of Amsterdam, Amsterdam, Netherlands
6Section of Hematology, Yale University School of Medicine, New Haven, CT
7Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA
8Division of Nephrology, Columbia University Irving Medical School, New York, NY
9Division of Thrombosis and Hemostasis, Beth Israel Deaconess Medical Center, Boston, MA
10Division of Hematology, Department of Medicine, Massachusetts General Hospital, Cambridge, MA

Christina Hart, MD1*, Robert Klamroth, MD2*, Ulrich J. Sachs, MD, PhD3*, Richard Greil, MD4, Paul N. Knoebl, MD5*, Johannes Oldenburg, MD6, Wolfgang Miesbach, MD7*, Christian Pfrepper, MD8*, Karolin Trautmann-Grill, MD9*, Isabell Pekrul, MD10*, Katharina Holstein, MD11*, Hermann Eichler, MD12*, Carmen Weigt13*, Dorothea Schipp13*, Sonja Werwitzke14* and Andreas Tiede, MD14

1Medical Clinic III, University Hospital Regensburg, Regensburg, Germany
2Internal Medicine, Vascular Medicine and Coagulation Disorders, Vivantes Clinic Friedrichshain, Berlin, Germany
3Department of Thrombosis and Haemostasis, Justus Liebig University, Giessen, Germany
4Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria
5Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria
6Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn AöR, Medical Faculty, Bonn, Germany
7Goethe University Hospital, Frankfurt, Germany
8Division of Hemostaseology, Medical Department I, University Hospital Leipzig, Leipzig, Germany
9Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Germany
10Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology, Department of Anaesthesiology, Hospital of Ludwig Maximilian University, Munich, Germany
11Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
12Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University, Homburg/Saar, Germany
13GWT-TUD GmbH, Dresden, Germany
14Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Robert F. Sidonio, MD, MSc1, Angela C Weyand, MD2, Tammuella Chrisentery-Singleton, MD3, Martin Chandler3*, Haduwa Momoh4*, Priscilla Driscoll-Shempp5*, Bethany Jones5*, Natalia Nieto, MD6* and Jorge Caicedo, MD7*

1Emory University, Atlanta, GA
2Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI
3American Thrombosis and Hemostasis Network, Rochester, NY
4ATHN, Louisiana
5Takeda Pharmaceuticals, U.S.A., Inc, Lexington
6Takeda, Lexington
7Takeda Pharmaceuticals, Lexington, MA

Kumpal Madrasi1*, Pratik Bhagunde1*, Sajida Iqbal2*, Marja Puurunen2*, Marek Demissie2*, Shauna Andersson2*, Sreeraj Macha1* and Malidi Ahamadi1*

1Sanofi, Bridgewater, NJ
2Sanofi, Cambridge, MA

Feng Xue, MD1*, Weizhi Chen2*, Shuxia Guo, MD3*, Haiying Hua, MD4*, Yu Cao5*, Xianqi Feng5* and Renchi Yang, MD1

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2People’s Hospital of Rizhao, Rizhao, China
3Zhengzhou People's Hospital, Zhengzhou, CHN
4Affiliated Hospital of Jiangnan University, Jiangsu, CHN
5Affiliated Hospital of Qingdao University, qingdao, China

Sheena Thakkar, MPH1*, Lisa Wilcox, PhD1*, Valeria Merla, MPH1*, Anna Kane, MSc1*, Jose Alvir, DrPH1*, Surya Pemmaraju, MSc1*, Ella Morton, BSc2*, Jade Garratt-Wheeldon, BSc2*, Nathan Ball, BSc2*, Stevie Olsen, BSc2* and Keisha Golden, BSc3*

1Pfizer Inc, New York, NY
2Adelphi Real World, Bollington, United Kingdom
3Adelphi Real World, Bollington, ENG, United Kingdom

Himil Mahadevia, MBBS1, Lisa McCamy2*, Yahia Mohamed2*, An-Lin Cheng, PhD2*, Suman Suman2*, William Jennings, MD, FACP3* and Anuj Shrestha, MD, FACP4

1Department of Internal Medicine, University of Missouri at Kansas City, Kansas City, MO
2Department of Biomedical and Health Informatics, University of Missouri at Kansas City, Kansas City, MO
3Bloch Cancer Center UH Truman Medical Center / Kansas City Regional Hemophilia Treatment Center, University of Missouri at Kansas City, Kansas City, MO
4Bloch Cancer Center UH Truman Medical Center/ Section of Hematology and Oncology, University of Missouri at Kansas City, Kansas City, MO

Michelle Millions, MD1*, Jaclyn Shelton, MD1* and Haowei (Linda) Sun, MD, MHSc2

1Department of Medicine, University of Alberta, Edmonton, AB, Canada
2Division of Hematology, Department of Medicine, University of Alberta, Edmonton, AB, Canada

Trevor Baglin1*, James A. Huntington, PhD2, Annelize Koch, MD3*, Irina Mocanu, MD4* and Levani Makhaldiani, MD5*

1ApcinteX Ltd (a subsidiary of Centessa Pharmaceuticals plc), Boston, MA
2Cambridge Institute for Medical Research University of Cambridge, Cambridge, GBR
3Simbec-Orion Clinical Pharmacology, Merthyr Tydfil, United Kingdom
4Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Moldova, The Republic of
5Arensia Exploratory Medicine, Tbilisi, Georgia

Ting-Wei Lyu, MBBS1*, Ting Sun1* and Sheng-Chieh Chou2*

1Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan

Meng-Ni Fan, PhD1*, Tangliang Shen2*, Xiaohe Cai1*, Ting-Yen Chao1*, Marilyn Manco-Johnson, MD3*, Weidong Xiao, PhD4*, Barbara A. Konkle, MD5,6, Lei Li, PhD2* and Carol H. Miao, PhD1,5

1Seattle Children's Research Institute, Seattle, WA
2Georgia State University, Atlanta, GA
3Children's Hospital Colorado, Aurora, CO
4Indiana University, Bloomington, IN
5University of Washington, Seattle, WA
6Washington Center For Bleeding Disorders, Seattle, WA

Aarthi Rajkumar, MD1, Nour Tashtish2* and Lalitha Nayak, MD3

1University Hospital Seidman cancer Center, Case Western Reserve University, Canal Fulton, OH
2Department of Medicine, Cleveland, OH
3Department of Medicine, Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH

Dandan Yu1*, Feng Xue, MD1*, Xiaofan Liu, MD2*, Yunfei Chen3*, Rongfeng Fu1*, Ting Sun1*, Xinyue Dai1*, Mankai Ju1*, Huan Dong1*, Renchi Yang, MD2, Wei Liu1* and Lei Zhang, MD4

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
3Tianjin Institutes of Health Science, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China

Yuan Xu1,2*, Ying Wang3*, Runhui Wu, MD4*, Changcheng Zheng, MD5*, Jianwen Xiao6*, Weiqun Xu7*, Xiaoqin Feng8*, Hua Wang9*, Xiangshan Cao10*, Liya He11*, Tianyang Xue12*, Mingwei Jin12*, Bingshou Xie13*, Jing Ling, PhD14*, Lirong Sun15*, Rui Su16*, Hongbo Cheng17*, Yongjun Fang18*, Bai Li19*, Ziqiang Yu20*, Ailing Xue21*, Mei Sun22*, Li Yang23*, Zeping Zhou24*, Hu Zhou, MD25*, Jiao Jin26*, Min Zhou27*, Rong Chen28*, Wei Liu, MD1,29*, Lei Zhang, MD2,30, Feng Xue, MD1,2* and Renchi Yang, MD1,31

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3Shenzhen Children's Hospital, Shenzhen, China
4Hematology Department, Beijing Children's Hospital, Affiliated to Capital Medical University, Beijing, China
5Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
6Department of Hematology, Children's Hospital of Chongqing Medical University, Chongqing, China
7Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
8Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
9Xi'an Children's Hospital, Xi'an, China
10Suzhou BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Suzhou, China
11Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
12Xuzhou Star Hospital, Xuzhou, China
13Department of Hematology, The Third Clinical Institute Affiliated to Wenzhou Medical University, People's Hospital of Wenzhou, Wenzhou, China
14Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
15Department of Pediatric Hematology and Oncology, Affiliated Hospital of Qingdao University, Qingdao, China
16Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China
17Department of Hematology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China
18Department of Hematology/Oncology, Children's Hospital of Nanjing Medical University, Nanjing, China
19Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
20National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China
21Zibo Central Hospital, Zibo, China
22Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China
23Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China
24Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
25Henan Cancer Hospital/The Affiliated Cancer Hospital of Zheng Zhou University, Zhengzhou, China
26Department of Pediatrics, Affiliated Hospital of Guizhou Medical University, Guiyang, China
27Chengdu Women's and Children's Central Hospital, Chengdu, China
28Hematology Department, Chengdu Third People's Hospital, Chengdu, China
29State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
30State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China
31State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Tadashi Matsushita1, Nobuaki Suzuki1*, Chiai Nagae2*, Azusa Nagao3*, Masahiko Ando1*, Yachiyo Kuwatsuka1*, Daisuke Nosaka4*, Yui Kyogoku4*, Tomomi Shimura4* and Keiji Nogami5*

1Nagoya University Hospital, Aichi, Japan
2St Marianna University School of Medicine, Kanagawa, Japan
3Ogikubo Hospital, Tokyo, Japan
4Chugai Pharmaceutical Co., Ltd, Tokyo, Japan
5Department of Pediatrics, Nara Medical University, Nara, Japan

Hanaisa P Sant'Anna, PhD1*, Julia Duarte2*, Ricardo M. Camelo, MD, PhD3*, Luciana Werneck Zuccherato2*, Renan P. Souza, PhD2*, Lucas Faria2*, Rafael Tou2*, Daniel Gonçalves Chaves4*, Eduardo Tarazona-Santos5* and Suely M. Rezende, MD, PhD6

1Universidade Federal de Minas Gerais, Belo Horizonte, AC, Brazil
2Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
3Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil
4Fundação HEMOMINAS, Belo Horizonte, Brazil
5Universidade Federal De Minas Gerais, Belo Horizonte, MG, BRA
6Universidade Federal de Minas Gerais, BELO HORIZONTE, AC, Brazil

Bradley Rutherford, MD1, Ellen Cusano, MD2, M. Dawn Goodyear, MD, MSc2 and Haowei (Linda) Sun, MD, MHSc3

1Department of Medicine, University of Alberta, Edmonton, AB, Canada
2Department of Medicine, Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, AB, Canada
3Division of Hematology, Department of Medicine, University of Alberta, Edmonton, AB, Canada

Wei Liu1,2*, Rongfu Zhou, MD, PhD3*, Panjing Wang4*, Hu Zhou, MD5*, Jie Bai, PhD6*, Xianghua Wang7*, Yueshen Ma1,2*, Zhen Song1,2*, Yunfei Chen1,2*, Xiaofan Liu, MD2,8*, Rongfeng Fu1,2*, Ting Sun1,2*, Mankai Ju1,2*, Xinyue Dai1,2*, Huan Dong1,2*, Feng Xue, MD1,2*, Renchi Yang, MD9 and Lei Zhang, MD2,10

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China
4Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5Henan Cancer Hospital/The Affiliated Cancer Hospital of Zheng Zhou University, Zhengzhou, China
6The Second Hospital of Tianjin Medical University, Tianjin, China
7Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, CHN
8Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
9Institute of Hematology & Blood Disease, Tianjin, CHN
10State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China

*signifies non-member of ASH